📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Safety and impact of eculizumab withdrawal in patients with atypical haemolytic uraemic syndrome: protocol for a multicentre, open-label, prospective, single-arm study. (2022)

First Author: Dunn S

Attributed to: Personalised management of atypical haemolytic uraemic syndrome funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1136/bmjopen-2021-054536

PubMed Identifier: 36123058

Publication URI: http://europepmc.org/abstract/MED/36123058

Type: Journal Article/Review

Volume: 12

Parent Publication: BMJ open

Issue: 9

ISSN: 2044-6055